Dimethylarginine Levels in Cerebrospinal Fluid of Hyperacute Ischemic Stroke Patients are Associated with Stroke Severity
- 104 Downloads
We hypothesise that asymmetric and symmetric dimethylarginine (ADMA, SDMA) are released in cerebrospinal fluid (CSF) due to ischemia-induced proteolysis and that CSF dimethylarginines are related to stroke severity. ADMA and SDMA were measured in CSF of 88 patients with ischemic stroke or TIA within 24 h after stroke onset (mean 8.6 h) and in 24 controls. Stroke severity was assessed by the National Institutes of Health Stroke Scale (NIHSS) score at admission. Outcome was evaluated by institutionalization due to stroke and the modified Rankin scale. Dimethylarginine levels were higher in patients with stroke than in TIA patients, who had higher levels than controls and correlated with the NIHSS. Logistic regression analysis confirmed that dimethylarginines were independently associated with stroke severity. The SDMA/ADMA ratio did not differ significantly between controls and stroke patients. CSF dimethylarginine levels are increased in hyperacute ischemic stroke and are associated with stroke severity.
KeywordsBrain ischemia Dimethylarginines Asymmetric dimethylarginine Symmetric dimethylarginine Cerebrospinal fluid Stroke
Modification of diet in renal diseases formula
Modified Rankin scale
Magnetic resonance imaging
National Institutes of Health Stroke Scale
Transient ischemic attack
R. B. is a research assistant of the Fund for Scientific research Flanders (FWO-Vlaanderen). This research was also supported by the Institute Born-Bunge; the agreement between the Institute Born-Bunge and the University of Antwerp; the Interuniversity Attraction Poles (IAP) program P6/43 of the Belgian Federal Science Policy Office, Belgium; and the Medical Research Foundation Antwerp.
- 8.Abe T, Tohgi H, Murata T, Isobe C, Sato C (2001) Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer’s disease. Neurosci Lett 312:177–179. doi: 10.1016/S0304-3940(01)02214-5 PubMedCrossRefGoogle Scholar
- 16.Brouns R, Sheorajpanday R, Kunnen J, De Surgeloose D, De Deyn PP (2009) Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome. Eur Neurol 774Google Scholar